Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cost Considerations for Monoclonal Antibody-Targeted Therapy in Cancer

Cost Considerations for Monoclonal Antibody-Targeted Therapy in Cancer Targeted cancer therapies make it possible to tailor cancer treatment. This individualization of treatment is based on the unique set of molecular targets produced by a patient’s tumor. By administering selective therapies, efficacy can be improved over current treatments with fewer normal cells harmed, thus lowering the occurrence of possible side effects and improving quality of life. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Cost Considerations for Monoclonal Antibody-Targeted Therapy in Cancer

American Journal of Cancer , Volume 5 (1) – Aug 10, 2012

Loading next page...
 
/lp/springer-journals/cost-considerations-for-monoclonal-antibody-targeted-therapy-in-cancer-QizYstk8Rw
Publisher
Springer Journals
Copyright
Copyright © 2006 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200605010-00003
Publisher site
See Article on Publisher Site

Abstract

Targeted cancer therapies make it possible to tailor cancer treatment. This individualization of treatment is based on the unique set of molecular targets produced by a patient’s tumor. By administering selective therapies, efficacy can be improved over current treatments with fewer normal cells harmed, thus lowering the occurrence of possible side effects and improving quality of life.

Journal

American Journal of CancerSpringer Journals

Published: Aug 10, 2012

References